Nephrocare Health Services, which operates dialysis service network NephroPlus, is planning to expand its domestic and international footprint in FY27, with new clinics planned across India and the Philippines, alongside its entry into Kazakhstan.
The company added 40 clinics in India and 11 in the Philippines during the first half of FY27, according to Group CEO Rohit Singh. The Philippines expansion comprised 10 acquired facilities and one newly established centre.
For the full financial year, NephroPlus is targeting the addition of 40-50 clinics in India and 15–16 clinics in the Philippines. The Philippines has become the company’s second-largest market, where it holds the position of the second-largest dialysis services provider.
During the July-September 2026 quarter (Q2FY27), Nephrocare Health Services recorded revenue of ₹303 crore, a profit of ₹34 crore and a margin of 22.10%. The company is aiming to achieve revenue growth of 15-20% CAGR over the next three to four years.
Entry into Kazakhstan Through Acquisitions
As part of its international growth strategy, Nephrocare has entered Kazakhstan by acquiring two dialysis clinics in the Almaty region. The move extends its presence in Central Asia, where it has already been operating in neighbouring Uzbekistan for five years.
The company plans to integrate the newly acquired facilities into its existing operations before considering further expansion. Singh expects the Kazakhstan business to achieve operational stability and appropriate margins within one year.
Saudi Arabia Expansion Through Healthcare Tender
Saudi Arabia remains another focus market for Nephrocare. The company entered the country through a joint venture three years ago and has since operationalised a clinic at Riyadh Hospital to demonstrate its clinical capabilities. It has also introduced a home haemodialysis programme.
Nephrocare is preparing to participate in a Ministry of Health tender covering four clusters, with bids scheduled for submission in February 2027. Twelve global participants have reportedly qualified at the technical stage.
According to Singh, geopolitical developments in West Asia had delayed some decision-making processes. However, the company is now concentrating on preparing its tender submission.
The planned expansion across India, Southeast Asia and Central Asia, along with its participation in the Saudi Arabian tender, forms part of Nephrocare’s strategy to strengthen its position in the international dialysis services market.
